Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
|
|
Invivyd, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/19/2022 |
SC 13D/A
| M28 Capital Management LP reports a 8.5% stake in Adagio Therapeutics, Inc. |
| 07/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2022 |
SC 13D/A
| Population Health Equity Partners III, L.P. reports a 1.1% stake in ADAGIO THERAPEUTICS, INC. |
| 06/24/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2022 |
SC 13D/A
| M28 Capital Management LP reports a 5.8% stake in Adagio Therapeutics, Inc. |
| 04/26/2022 |
SC 13D/A
| M28 Capital Management LP reports a 5.8% stake in Adagio Therapeutics, Inc. |
| 04/25/2022 |
SC 13D/A
| Population Health Equity Partners III, L.P. reports a 1.1% stake in ADAGIO THERAPEUTICS, INC. |
| 04/25/2022 |
SC 13D/A
| Polaris Venture Partners V, L.P. reports a 7.8% stake in ADAGIO THERAPEUTICS, INC. |
| 03/30/2022 |
SC 13D/A
| Polaris Venture Partners V, L.P. reports a 7.7% stake in ADAGIO THERAPEUTICS, INC. |
| 03/30/2022 |
SC 13D/A
| MITHRIL II LP reports a 10.1% stake in ADAGIO THERAPEUTICS, INC. |
|
|